Wu, Xifeng <br/><br/>
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Aug 2006 
 - 3789-98 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2005.03.6640  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Carcinoma, Squamous Cell--drug therapy<br/>Chemotherapy, Adjuvant<br/>Critical Pathways<br/>DNA-Binding Proteins--genetics<br/>Dose Fractionation, Radiation<br/>Esophageal Neoplasms--drug therapy<br/>Esophagectomy--methods<br/>Esophagogastric Junction<br/>Female<br/>Fluorouracil--administration & dosage<br/>Genes, MDR<br/>Genotype<br/>Humans<br/>Male<br/>Methylenetetrahydrofolate Reductase (NADPH2)--genetics<br/>Middle Aged<br/>Neoadjuvant Therapy--methods<br/>Odds Ratio<br/>Platinum Compounds--administration & dosage<br/>Polymorphism, Single Nucleotide<br/>Predictive Value of Tests<br/>Prognosis<br/>Proportional Hazards Models<br/>Radiotherapy, Adjuvant<br/>Retrospective Studies<br/>Risk Assessment<br/>Stomach Neoplasms--drug therapy<br/>Survival Analysis<br/>Taxoids--administration & dosage<br/>Treatment Outcome<br/>X-ray Repair Cross Complementing Protein 1